Immunotherapy linked to lower risk of Alzheimer's disease

Jul 20, 2009

IVIg treatments, the addition of good antibodies into the blood stream, may hold promise for lowering the risk of Alzheimer's disease and other similar brain disorders, according to research published in the July 21, 2009, print issue of Neurology, the medical journal of the American Academy of Neurology.

"In our study, we looked at the association of the use of intravenous immunoglobulin (IVIg) with the occurrence of Alzheimer's disease. IVIg has been used safely for more than 20 years to treat other diseases but is thought to have an indirect effect on Alzheimer's disease by targeting beta-amyloid, or plaques in the brain," said Howard Fillit, MD, with the Mount Sinai School of Medicine in New York.

For the study, researchers analyzed the medical records of 847 people given at least one treatment of IVIg over four years and 84,700 who were not given IVIg treatment. Participants were treated for deficiencies, leukemia or other types of cancer, anemia and other diseases. The records were pulled from a database of 20 million patients age 65 or older developed by SDI Health. Scientists made sure the groups were similar in their risk factors for Alzheimer's disease.

The study found that people who received IVIg for other conditions had a 42-percent lower risk of developing Alzheimer's disease over four years compared to those who did not receive IVIg. Only 2.8 percent of those treated with IVIg developed Alzheimer's disease compared with 4.8 percent of those not treated with immune-based therapy.

"Our study provides evidence that previous IVIg treatments may protect against Alzheimer's disease," said Fillit. "The current Alzheimer's drugs on the market treat the symptoms of the disease. Immunization could treat the underlying cause."

"These findings do not constitute an endorsement of IVIg treatment for . A large scale clinical trial is underway to determine whether IVIg could be an effective treatment for Alzheimer's," researchers said.

Source: American Academy of Neurology (news : web)

Explore further: A gut bacterium that attacks dengue and malaria pathogens and their mosquito vectors

add to favorites email to friend print save as pdf

Related Stories

Blood inflammation plays role in Alzheimer's disease

May 28, 2007

People whose blood shows signs of inflammation are more likely to later develop Alzheimer's disease than people with no signs of inflammation, according to a study published in the May 29, 2007, issue of Neurology®, the ...

Does growth hormone drug slow Alzheimer's disease?

Nov 17, 2008

A new study shows that a drug that increases the release of growth hormone failed to slow the rate of progression of Alzheimer's disease in humans. The new research is published in the November 18, 2008, print issue of Neurology, the me ...

Physical frailty may be linked to Alzheimer's disease

Aug 11, 2008

Physical frailty, which is common in older persons, may be related to Alzheimer's disease pathology, according to a study published in the August 12, 2008, issue of Neurology, the medical journal of the American Academy of Neu ...

Having a parent with dementia may affect memory in midlife

Feb 18, 2009

People who have parents diagnosed with Alzheimer's disease or dementia may be more likely to have memory loss themselves in middle age, according to a study released today that will be presented at the American Academy of ...

Recommended for you

After alarm, Lebanese man tests negative for Ebola (Update)

3 hours ago

A Lebanese man who arrived in Beirut from West Africa believing he may have Ebola was reassured by doctors that he is disease free but was still taken into a hospital quarantine on Thursday as a practice run to check the ...

New, faster therapeutic hypothermia techniques

3 hours ago

Rapid lowering of body temperature following an acute myocardial infarction (MI) can be an effective therapeutic strategy to minimize damage to the heart muscle caused by the loss and restoration of blood ...

User comments : 0